Differential Effects of Mesenchymal Stem Cell- and Natural Killer Cell-Derived Extracellular Vesicles on Cisplatin Responsiveness in Endometrial Cancer Cells
International Journal of Molecular Sciences · 28.06.2026 · 27 (13) · 5842
DOI: 10.3390/ijms27135842 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 28.06.2026. Verfasst von Ren-Jun Hsu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Center, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 970473, Taiwan. Hauptthemen laut MEDLINE: Cisplatin, Endometrial Neoplasms, Mesenchymal Stem Cells, Extracellular Vesicles. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tri-Service General Hospital, Tzu Chi Foundation, Hualien Tzu Chi Medical Center.
Abstract (Originalsprache)
Cisplatin (cis-diamminedichloroplatinum(II) [DDP]) is a key chemotherapeutic agent for advanced endometrial cancer; however, chemoresistance substantially limits its clinical benefit. Extracellular vesicles (EVs) mediate intercellular communication and influence tumour cell behaviour and therapeutic response. We investigated whether mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) and natural killer cell-derived extracellular vesicles (NK-EVs) modulate cisplatin responsiveness in endometrial cancer cells (RL95-2 and HEC-1A). MSC-EVs and NK-EVs were isolated and characterised using nanoparticle tracking analysis, scanning electron microscopy, and EV marker profiling. MSC-EVs and NK-EVs reduced RL95-2 and HEC-1A cell viability in a dose-dependent manner, with MSC-EVs exhibiting substantial effects at lower particle concentrations. In a cisplatin-resistant HEC-1A (HEC-1A DDP-R) model, MSC-EVs were associated with greater reductions in cell viability under cisplatin treatment conditions, whereas NK-EVs showed comparatively modest effects. Mechanistic analyses demonstrated altered expression of apoptosis- and cell cycle–related proteins, including increased cleaved poly(ADP-ribose) polymerase and cleaved caspase-3 levels and reduced cyclin A and cyclin D1 expression following MSC-EV treatment. Annexin V-fluorescein isothiocyanate/propidium iodide flow cytometry demonstrated increased apoptotic cell populations after MSC-EV treatment, with MSC-EV + DDP co-treatment resulting in the highest apoptotic fraction in chemoresistant HEC-1A cells. Collectively, these findings indicate that MSC-EVs are associated with altered cellular responses to cisplatin in chemoresistant endometrial cancer cells, accompanied by changes in apoptosis-related protein expression, apoptotic cell populations, and cell-cycle regulators. Further investigation is required to determine their mechanistic role and therapeutic potential in overcoming chemoresistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Center, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 970473, Taiwan.
- School of Medicine, Tzu Chi University, Hualien 970374, Taiwan.
- Department of BioMedical Engineering, Ming Chuan University, Taoyuan 333321, Taiwan.
- Graduate Institute of Life Sciences, College of Biomedical Sciences, National Defense Medical University, Taipei 114, Taiwan.
- Graduate Institute of Pathology and Parasitology, College of Medicine, National Defense Medical University, Taipei 114, Taiwan.
- Department of Pathology, Tri-Service General Hospital, National Defense Medical University, Taipei 114, Taiwan.
ORCID-Profile: Ren-Jun Hsu, Cheng-Shuo Huang, Zheng-Zong Lai, Cheng-Ping Yu, Jar-Yi Ho, Fung-Wei Chang
Förderung
- Tri-Service General Hospital
- Tzu Chi Foundation
- Hualien Tzu Chi Medical Center
- Tri-Service General Hospital Penghu Branch
- Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
- Teh-Tzer Study Group for Human Medical Research Foundation
- Hualien Tzu Chi Hospital and Buddhist Tzu Chi Medical Foundation
Zitieren
APA
Hsu, R. J., Huang, C. S., Yeh, M. K., Lai, Z. Z., Yu, C. P., Ho, J. Y., & Chang, F. W. (2026). Differential Effects of Mesenchymal Stem Cell- and Natural Killer Cell-Derived Extracellular Vesicles on Cisplatin Responsiveness in Endometrial Cancer Cells. International Journal of Molecular Sciences, 27(13), 5842. https://doi.org/10.3390/ijms27135842
Vancouver
Hsu RJ, Huang CS, Yeh MK, Lai ZZ, Yu CP, Ho JY, et al. Differential Effects of Mesenchymal Stem Cell- and Natural Killer Cell-Derived Extracellular Vesicles on Cisplatin Responsiveness in Endometrial Cancer Cells. International Journal of Molecular Sciences. 2026;27(13):5842. doi:10.3390/ijms27135842
BibTeX
@article{Hsu2026,
author = {Hsu, Ren-Jun and Huang, Cheng-Shuo and Yeh, Ming-Kung and Lai, Zheng-Zong and Yu, Cheng-Ping and Ho, Jar-Yi and Chang, Fung-Wei},
title = {Differential Effects of Mesenchymal Stem Cell- and Natural Killer Cell-Derived Extracellular Vesicles on Cisplatin Responsiveness in Endometrial Cancer Cells},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {13},
pages = {5842},
doi = {10.3390/ijms27135842}
}
EUVIMED